Direct Medical Cost of Stroke and the Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation-Related Stroke: A Cross-Sectional Study

Background: Stroke has significant direct medical costs, and direct oral anticoagulants (DOACs) are better alternatives to warfarin for stroke prevention in atrial fibrillation (AF). This study aimed to determine the direct medical costs of stroke, with emphasis on AF stroke and the cost-effectivene...

Descripción completa

Detalles Bibliográficos
Autores principales: Azahar, Siti Norain, Sulong, Saperi, Wan Zaidi, Wan Asyraf, Muhammad, Norliza, Kamisah, Yusof, Masbah, Norliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834259/
https://www.ncbi.nlm.nih.gov/pubmed/35162102
http://dx.doi.org/10.3390/ijerph19031078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834259/
https://www.ncbi.nlm.nih.gov/pubmed/35162102
http://dx.doi.org/10.3390/ijerph19031078

Ejemplares similares